SCHEMBL71363

SCHEMBL71363

Cc1cccc(NC2CCN(C(=O)OC(C)(C)C)CC2)c1C

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.57
HTT P42858 2/20 0.56
MAPT P10636 2/20 0.56
NPC1 O15118 1/20 0.56
MAPK1 P28482 1/20 0.56
RAB9A P51151 1/20 0.56
L3MBTL1 Q9Y468 1/20 0.56
TGFBR1 P36897 1/20 0.50
BTK Q06187 1/20 0.50
BRD4 O60885 1/20 0.50
GPR119 Q8TDV5 3/20 0.49
EPHX1 P07099 1/20 0.48
CNR1 P21554 1/20 0.48
STS P08842 1/20 0.47
PTPN2 P17706 1/20 0.47
PTPN1 P18031 1/20 0.47
PTPN6 P29350 1/20 0.47
KDM4E B2RXH2 1/20 0.46
PKM P14618 1/20 0.46
KMT2A Q03164 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL70137 0.90 ALDH1A1 (0.59) ALDH1A1HTTMAPTNPC1MAPK1
SCHEMBL7406814 0.86 ALDH1A1 (0.53) ALDH1A1HTTMAPTNPC1MAPK1
SCHEMBL28498760 0.84 ALDH1A1 (0.51) ALDH1A1HTTMAPTNPC1MAPK1
SCHEMBL12069062 0.82 ALDH1A1 (0.59) ALDH1A1HTTMAPTNPC1MAPK1
SCHEMBL2606333 0.82 ALDH1A1 (0.59) ALDH1A1HTTMAPTNPC1MAPK1
SCHEMBL24368293 0.82 ALDH1A1 (0.56) ALDH1A1HTTMAPTNPC1MAPK1
SCHEMBL29198209 0.82 ALDH1A1 (0.54) ALDH1A1HTTMAPTNPC1MAPK1
SCHEMBL4302207 0.82 ALDH1A1 (0.54) ALDH1A1HTTMAPTNPC1MAPK1
SCHEMBL27833477 0.82 MAPT (0.47) ALDH1A1HTTMAPTNPC1MAPK1
SCHEMBL25010687 0.82 ALDH1A1 (0.55) ALDH1A1HTTMAPTRAB9ABTK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8129376-B2 Piperidine derivatives as inhibitors of stearoyl-CoA desaturase AURIGENE DISCOVERY TECHNOLOGIES LIMITED (IN) 2012-03-06 US disclosed
EP-2268143-A2 NOVEL PIPERIDINE DERIVATIVES AS INHIBITORS OF STEAROYL-COA DESATURASE Forest Laboratories Holdings Limited (BM) 2011-01-05 EP disclosed
US-20090239810-A1 NOVEL PIPERAZINE DERIVATIVES AS INHIBITORS OF STEAROYL-CoA DESATURASE FOREST LABORATORIES HOLDINGS LIMITED (BM) 2009-09-24 US disclosed
WO-2009117676-A2 NOVEL PIPERIDINE DERIVATIVES AS INHIBITORS OF STEAROYL-COA DESATURASE FOREST LABORATORIES HOLDINGS LIMITED (BM) 2009-09-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090239810-A1 NOVEL PIPERAZINE DERIVATIVES AS INHIBITORS OF STEAROYL-CoA DESATURASE SCD, SCD5, FADS2 ALDH1A1 784/4885HTT 3258/4885MAPT 3456/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.